[
  {
    "date": "2023-12-30",
    "symbol": "NTLA",
    "period": "FY",
    "netincomeloss": -481192000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NTLA",
    "entityregistrantname": "INTELLIA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1652130,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-37766",
    "entitytaxidentificationnumber": "36-4785571",
    "entityaddressaddressline1": "40 Erie Street",
    "entityaddressaddressline2": "Suite 130",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "285-6200",
    "entityincorporationstatecountrycode": "DE",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Boston, Massachusetts",
    "documentfinstmterrorcorrectionflag": "false",
    "cashandcashequivalentsatcarryingvalue": 226748000,
    "marketablesecuritiescurrent": 685475000,
    "accountsreceivablenetcurrent": 200000,
    "prepaidexpenseandotherassetscurrent": 49651000,
    "assetscurrent": 998330000,
    "marketablesecuritiesnoncurrent": 99864000,
    "propertyplantandequipmentnet": 32760000,
    "operatingleaserightofuseasset": 115375000,
    "equitymethodinvestments": 11765000,
    "investmentsandothernoncurrentassets": 42883000,
    "assets": 1300977000,
    "accountspayablecurrent": 7452000,
    "accruedliabilitiescurrent": 67017000,
    "operatingleaseliabilitycurrent": 18599000,
    "contractwithcustomerliabilitycurrent": 22140000,
    "liabilitiescurrent": 115208000,
    "contractwithcustomerliabilitynoncurrent": 38853000,
    "operatingleaseliabilitynoncurrent": 96747000,
    "liabilities": 250808000,
    "commonstockvalue": 9000,
    "additionalpaidincapitalcommonstock": 2710797000,
    "accumulatedothercomprehensiveincomelossnetoftax": -2258000,
    "retainedearningsaccumulateddeficit": -1658379000,
    "stockholdersequity": 1050169000,
    "liabilitiesandstockholdersequity": 1300977000,
    "otherreceivablesnetcurrent": 1000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 240000000,
    "commonstocksharesissued": 92997158,
    "commonstocksharesoutstanding": 92997158,
    "revenuefromcontractwithcustomerexcludingassessedtax": 36275000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#LicenseAndServiceMember",
    "researchanddevelopmentexpense": 435069000,
    "generalandadministrativeexpense": 116497000,
    "costsandexpenses": 551566000,
    "operatingincomeloss": -515291000,
    "investmentincomeinterest": 49832000,
    "incomelossfromequitymethodinvestments": -15633000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 100000,
    "othernonoperatingincomeexpense": 34099000,
    "earningspersharebasic": -5.42,
    "earningspersharediluted": -5.42,
    "weightedaveragenumberofsharesoutstandingbasic": 88770000,
    "weightedaveragenumberofdilutedsharesoutstanding": 88770000,
    "marketablesecuritiesunrealizedgainloss": 3635000,
    "othercomprehensiveincomelossreclassificationadjustmentfromaociforinvestmenttransferredfromavailableforsaletoequitymethodtax": 1568000,
    "comprehensiveincomenetoftax": -475989000,
    "revenuefromrelatedparty": 12832000,
    "stockissuedduringperiodvaluenewissues": 121870000,
    "stockissuedduringperiodsharesnewissues": 4122824,
    "contingentconsiderationsharespaidtorewriteholders": 567045,
    "contingentconsiderationpaidtorewriteholders": 24126000,
    "stockissuedduringperiodvaluestockoptionsexercised": 6599000,
    "stockissuedduringperiodsharesstockoptionsexercised": 385130,
    "stockissuedduringperiodsharesvestingrestrictedunits": 677055,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 3929000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 142097,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 134050000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 3635000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 376000,
    "profitloss": -481192000,
    "depreciationdepletionandamortization": 8976000,
    "gainlossonsaleofpropertyplantequipment": -72000,
    "sharebasedcompensation": 134050000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 25897000,
    "equitymethodinvestmentsoldcarryingamount": 6624000,
    "increasedecreaseinaccountsreceivable": 32688000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 27168000,
    "increasedecreaseinoperatingrightofuseassets": -19011000,
    "increasedecreaseinotheroperatingassets": 707000,
    "increasedecreaseinaccountspayable": 2522000,
    "increasedecreaseinaccruedliabilities": 6024000,
    "increasedecreaseincontractwithcustomerliability": -2778000,
    "increasedecreaseinoperatingleaseliabilities": -16668000,
    "netcashprovidedbyusedinoperatingactivities": -394086000,
    "paymentstoacquirepropertyplantandequipment": 13985000,
    "paymentstoacquiremarketablesecurities": 904464000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 887102000,
    "netcashprovidedbyusedininvestingactivities": -31347000,
    "proceedsfromissuanceofcommonstock": 119795000,
    "proceedsfromstockoptionsexercised": 6599000,
    "proceedsfromstockplans": 3929000,
    "netcashprovidedbyusedinfinancingactivities": 130323000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -295110000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 240353000,
    "restrictedcashequivalents": 13605000,
    "capitalexpendituresincurredbutnotyetpaid": 1525000,
    "sharesissuedforrewritecontingentconsideration": 24126000,
    "rightofuseassetsacquiredunderoperatinglease": 1311000,
    "proceedsfromatthemarketofferingsunpaidatperiodend": 2075000,
    "paymentstoacquirebusinessesnetofcashacquired": 287000,
    "restrictedcashequivalentsassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AssetsCurrent",
    "percentagelikelihoodofrealizationrequiredtorecordtaxbenefit": 0.5,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember",
    "availableforsaledebtsecuritiesamortizedcostbasis": 382260000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 302000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 254000,
    "availableforsalesecuritiesdebtsecurities": 382308000,
    "availableforsalessecuritiesnoncurrentmaturityperiod": "P1Y",
    "cashandcashequivalentsfairvaluedisclosure": 136254000,
    "investmentsfairvaluedisclosure": 382308000,
    "assetsfairvaluedisclosure": 921593000,
    "investmentownedatfairvalue": 14800000,
    "researchmilestonepayments": 25000000,
    "contingentconsiderationclassifiedasequityfairvaluedisclosure": 100000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": -24126000,
    "propertyplantandequipmentgross": 63970000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 39861000,
    "accruedresearchanddevelopmentexpensescurrent": 27411000,
    "employeerelatedliabilitiescurrent": 26615000,
    "accruedprofessionalfeescurrent": 2063000,
    "accruedconstructioncosts": 6891000,
    "otheraccruedliabilitiescurrent": 4037000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.086,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.069,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.016,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.349,
    "deferredtaxassetsoperatinglosscarryforwards": 258664000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 151333000,
    "deferredtaxassetscapitalizedresearch": 150993000,
    "deferredtaxassetsoperatingleaseliability": 31183000,
    "deferredtaxassetsdeferredincome": 9633000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 30408000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 6244000,
    "prepaidrent": 1190000,
    "deferredtaxassetsequitymethodinvestments": 7580000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1017000,
    "deferredtaxassetsdeferredexpensecapitalizedstartup": 249000,
    "deferredtaxassetsgross": 648494000,
    "deferredtaxassetsvaluationallowance": 616082000,
    "deferredtaxassetsnet": 32412000,
    "deferredtaxliabilitiespropertyplantandequipment": 1221000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 31191000,
    "deferredincometaxliabilities": 32412000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 954000000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 365800000,
    "significantchangeinunrecognizedtaxbenefitsisreasonablypossibleotherinformation": "The Company will amortize these costs for tax purposes over 5 years if the research and development was performed in the U.S. and over 15 years if the research and development was performed outside the U.S.",
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 36900000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetsoperatinglosscarryforwardsbeginstoexpireyear": 2034,
    "netoperatinglosscarryoverpercentageoftaxableincome": 1,
    "periodforwhichtaxableincomeavailablefromlosswasgenerated": "P20Y",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 917100000,
    "increaseindeferredtaxassetsvaluationallowance": 161300000,
    "deferredtaxassetstaxcreditcarryforwards": 100700000,
    "deferredtaxassetstaxcreditcarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetstaxcreditcarryforwardsbegintoexpireyear": 2034,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2029,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationdescription": "begin to expire in 2029",
    "contractwithcustomerliabilityadditions": 75000000,
    "increaseinaccountsreceivables": 51421000,
    "decreaseinaccountsreceivables": 18733000,
    "contractwithcustomerliability": 60993000,
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinmeasureofprogress": 40312000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": -43090000,
    "contractwithcustomerliabilityrevenuerecognized": 23462000,
    "contractwithcustomerliabilityextensionfee": 30000000,
    "saleofstocknumberofsharesissuedintransaction": 3739515,
    "saleofstockconsiderationreceivedontransaction": 3000000,
    "transactionprice": 51700000,
    "amountallocatedtolicensestotargetsandassociatedresearchactivitiesandevaluationplans": 48300000,
    "amountallocatedtotechnologycollaborationandresearchactivities": 3400000,
    "cumulativecatchupadjustment": 10300000,
    "remainingtransactionpricetransferredatinceptionofarrangement": 11400000,
    "transactionpriceallocatedtocombinedperformanceobligation": 51700000,
    "paymentsduefromaffiliates": 19600000,
    "revenueremainingperformanceobligation": 47100000,
    "accountsreceivablenet": 35700000,
    "revenuefromcontractwithcustomerincludingassessedtax": 400000,
    "equitymethodinvestmentownershippercentage": 0.3333,
    "investmentsinandadvancestoaffiliatesatfairvaluegrossreductions": 14100000,
    "saleofstockconsiderationreceivedpertransaction": 7000000,
    "businesscombinationupfrontcashconsideration": 43730000,
    "businesscombinationresearchcontingentconsiderationliabilities": 10541000,
    "businessacquisitioncostofacquiredentitytransactioncost": 1838000,
    "businesscombinationconsiderationtransferred1": 56109000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedinprocessresearchanddevelopment": 55990000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 287000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedassets": 153000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedliabilities": 321000,
    "businesscombinationtransactionprice": 56109000,
    "operatingleaseliability": 115346000,
    "areaofspaceleased": 230000,
    "operatingleasecost": 27849000,
    "variableleasecost": 6991000,
    "subleaseincome": 1439000,
    "leasecost": 33401000,
    "operatingleasepayments": 25456000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1311000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.0737,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 26395000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 25933000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 25110000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 17548000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 12300000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 39260000,
    "lesseeoperatingleaseliabilitypaymentsdue": 146546000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 31200000,
    "allocatedsharebasedcompensationexpense": 82211000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Stock options granted under the 2015 Plan in 2023 generally vest as to one-third on the first anniversary of the original vesting date, with the balance vesting monthly over the remaining two years, unless they contain specific performance-based vesting provisions. The maximum term of stock options granted under the 2015 Plan is ten years.",
    "commonstockcapitalsharesreservedforfutureissuance": 3875539,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 41.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalueamount": 24900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 3047544,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 677055,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.044,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.787,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 125200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 28.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 7600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 56100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 4041753,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiod": 270115,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 50.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 68.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiodweightedaveragegrantdatefairvalue": 49.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.047,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.604,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.692,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5458999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 569821,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 197367,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4017227,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 50.38,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 41,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 17.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 73.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 43.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y7M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 35922000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 34790000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4042000,
    "sharesissuedpricepershare": 30.57,
    "numberofremainingshareseligibleforsaleunderagreementvalue": 79000000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.5,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 3300000
  },
  {
    "date": "2022-12-30",
    "symbol": "NTLA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NTLA",
    "entityregistrantname": "INTELLIA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1652130,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-37766",
    "entitytaxidentificationnumber": "36-4785571",
    "entityaddressaddressline1": "40 Erie Street",
    "entityaddressaddressline2": "Suite 130",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "285-6200",
    "entityincorporationstatecountrycode": "DE",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 523506000,
    "marketablesecuritiescurrent": 669116000,
    "accountsreceivablenetcurrent": 3768000,
    "prepaidexpenseandotherassetscurrent": 20407000,
    "assetscurrent": 1216797000,
    "marketablesecuritiesnoncurrent": 69338000,
    "propertyplantandequipmentnet": 27921000,
    "operatingleaserightofuseasset": 133076000,
    "equitymethodinvestments": 32455000,
    "investmentsandothernoncurrentassets": 40527000,
    "assets": 1520114000,
    "accountspayablecurrent": 5154000,
    "accruedliabilitiescurrent": 60876000,
    "operatingleaseliabilitycurrent": 16685000,
    "contractwithcustomerliabilitycurrent": 43839000,
    "liabilitiescurrent": 126554000,
    "contractwithcustomerliabilitynoncurrent": 19932000,
    "operatingleaseliabilitynoncurrent": 114018000,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 24026000,
    "commonstockvalue": 9000,
    "additionalpaidincapitalcommonstock": 2420223000,
    "accumulatedothercomprehensiveincomelossnetoftax": -7461000,
    "retainedearningsaccumulateddeficit": -1177187000,
    "stockholdersequity": 1235584000,
    "liabilitiesandstockholdersequity": 1520114000,
    "accountsreceivablerelatedpartiescurrent": 300000,
    "duetorelatedpartiescurrent": 1600000,
    "contractwithcustomerliabilityrelatedpartycurrent": 19900000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 87103007,
    "commonstocksharesoutstanding": 87103007,
    "revenuefromcontractwithcustomerexcludingassessedtax": 52121000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseAndServiceMember",
    "researchanddevelopmentexpense": 419979000,
    "generalandadministrativeexpense": 90306000,
    "costsandexpenses": 510285000,
    "operatingincomeloss": -458164000,
    "investmentincomeinterest": 8542000,
    "incomelossfromequitymethodinvestments": -11079000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 13485000,
    "othernonoperatingincomeexpense": -16022000,
    "netincomeloss": -474186000,
    "earningspersharebasic": -6.16,
    "earningspersharediluted": -6.16,
    "weightedaveragenumberofsharesoutstandingbasic": 76972000,
    "weightedaveragenumberofdilutedsharesoutstanding": 76972000,
    "marketablesecuritiesunrealizedgainloss": -1637000,
    "othercomprehensiveincomelossreclassificationadjustmentfromaociforinvestmenttransferredfromavailableforsaletoequitymethodtax": -3192000,
    "comprehensiveincomenetoftax": -479015000,
    "revenuefromrelatedparties": 21134000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 253000,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 7532751,
    "stockissuedduringperiodvaluestockoptionsexercised": 14517000,
    "stockissuedduringperiodsharesstockoptionsexercised": 883954,
    "vestingrestrictedstockunits": 147674000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 77618000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 91400000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -1637000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -3192000,
    "profitloss": -474186000,
    "depreciationdepletionandamortization": 7572000,
    "gainlossonsaleofpropertyplantequipment": 162000,
    "sharebasedcompensation": 91400000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -4003000,
    "equitymethodinvestmentsoldcarryingamount": 11405000,
    "researchanddevelopmentinprocess": 55990000,
    "increasedecreaseinaccountsreceivable": 1737000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2160000,
    "increasedecreaseinoperatingrightofuseassets": -13121000,
    "increasedecreaseinotheroperatingassets": 1091000,
    "increasedecreaseinaccountspayable": -4584000,
    "increasedecreaseinaccruedliabilities": 15924000,
    "increasedecreaseincontractwithcustomerliability": -63464000,
    "increasedecreaseinoperatingleaseliabilities": -9882000,
    "netcashprovidedbyusedinoperatingactivities": -333287000,
    "paymentstoacquirepropertyplantandequipment": 13558000,
    "paymentstoacquiremarketablesecurities": 429032000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 647581000,
    "proceedsfromsaleofpropertyplantandequipment": 150000,
    "paymentstoacquireinprocessresearchanddevelopment": 44832000,
    "netcashprovidedbyusedininvestingactivities": 160309000,
    "proceedsfromissuanceofcommonstock": 337892000,
    "proceedsfromstockoptionsexercised": 14517000,
    "proceedsfromstockplans": 2649000,
    "netcashprovidedbyusedinfinancingactivities": 582955000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 409977000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 535463000,
    "restrictedcashequivalents": 11957000,
    "capitalexpendituresincurredbutnotyetpaid": 1623000,
    "rightofuseassetsacquiredunderoperatinglease": 67053000,
    "assetacquisitioncontingentconsiderationliability": 10541000,
    "noncashtradeinofpropertyandequipment": 200000,
    "paymentstoacquirebusinessesnetofcashacquired": 287000,
    "restrictedcashequivalentsassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#AssetsCurrent",
    "percentagelikelihoodofrealizationrequiredtorecordtaxbenefit": 0.5,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "5 years or term of respective lease, if shorter",
    "availableforsaledebtsecuritiesamortizedcostbasis": 244562000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 62000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1938000,
    "availableforsalesecuritiesdebtsecurities": 242686000,
    "availableforsalessecuritiesnoncurrentmaturityperiod": "P1Y",
    "cashandcashequivalentsfairvaluedisclosure": 534581000,
    "investmentsfairvaluedisclosure": 242686000,
    "assetsfairvaluedisclosure": 1273035000,
    "researchmilestonepayments": 25000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 24026000,
    "contingentconsiderationclassifiedasequityfairvaluedisclosure": 13485000,
    "discountrate": 0.101,
    "probabilityofachievement": 1,
    "projectedyearofachievement": 2023,
    "propertyplantandequipmentgross": 51911000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 33199000,
    "accruedresearchanddevelopmentexpensescurrent": 32684000,
    "employeerelatedliabilitiescurrent": 21778000,
    "accruedprofessionalfeescurrent": 1457000,
    "otheraccruedliabilitiescurrent": 4957000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.083,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.053,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.001,
    "effectiveincometaxratereconciliationonesixtytwom": 0.001,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.025,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.321,
    "deferredtaxassetsinprocessresearchanddevelopment": 79803000,
    "deferredtaxassetsdeferredexpensecapitalizedstartup": 296000,
    "deferredtaxassetsoperatinglosscarryforwards": 229375000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 101326000,
    "deferredtaxassetsoperatingleaseliability": 35386000,
    "deferredtaxassetsdeferredincome": 13189000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 22512000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 4968000,
    "prepaidrent": 1367000,
    "deferredtaxassetsequitymethodinvestments": 3358000,
    "deferredtaxassetsgross": 491580000,
    "deferredtaxassetsvaluationallowance": 454793000,
    "deferredtaxassetsnet": 36787000,
    "deferredtaxliabilitiespropertyplantandequipment": 759000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 36028000,
    "deferredincometaxliabilities": 36787000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 852100000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 36900000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetsoperatinglosscarryforwardsbeginstoexpireyear": 2034,
    "netoperatinglosscarryoverpercentageoftaxableincome": 1,
    "periodforwhichtaxableincomeavailablefromlosswasgenerated": "P20Y",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 815200000,
    "increaseindeferredtaxassetsvaluationallowance": 150000000,
    "deferredtaxassetstaxcreditcarryforwards": 63400000,
    "deferredtaxassetstaxcreditcarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetstaxcreditcarryforwardsbegintoexpireyear": 2034,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2029,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationdescription": "begin to expire in 2029",
    "contractwithcustomerliabilityadditions": 11400000,
    "increaseinaccountsreceivables": 12453000,
    "decreaseinaccountsreceivables": 10716000,
    "contractwithcustomerliability": 63771000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": -63464000,
    "contractwithcustomerliabilityrevenuerecognized": 52060000,
    "saleofstocknumberofsharesissuedintransaction": 3739515,
    "saleofstockconsiderationreceivedontransaction": 3000000,
    "businesscombinationconsiderationtransferred1": 56109000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "Through December 31, 2022",
    "paymentsduefromaffiliates": 11900000,
    "revenueremainingperformanceobligation": 28800000,
    "accountsreceivablerelatedparties": 3200000,
    "revenuefromcontractwithcustomerincludingassessedtax": 6600000,
    "investmentownedatfairvalue": 10000000,
    "investmentsinandadvancestoaffiliatesatfairvaluegrossreductions": 14300000,
    "saleofstockconsiderationreceivedpertransaction": 7000000,
    "businesscombinationupfrontcashconsideration": 43730000,
    "businesscombinationresearchcontingentconsiderationliabilities": 10541000,
    "businessacquisitioncostofacquiredentitytransactioncost": 1838000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedinprocessresearchanddevelopment": 55990000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 287000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedassets": 153000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedliabilities": 321000,
    "businesscombinationtransactionprice": 56109000,
    "lesseeoperatingleasedescription": "In October 2014, the Company entered into an agreement to lease office and laboratory space at 130 Brookline Street in Cambridge, Massachusetts under an operating lease agreement with a term through January 2020. In April 2019, the lease was amended to extend the term for an additional five-year period, through January 2025.",
    "lesseeoperatingleaseextendedexpirationdate": "2031-01-31",
    "lesseeoperatingleaseoptiontoextend": "In April 2019, the lease was amended to extend the term for an additional five-year period, through January 2025",
    "lesseeoperatingleaserenewalterm": "P6Y",
    "lesseeoperatingleaseleasenotyetcommencedbaserentpersquarefootforlastyearpercentage": 0.03,
    "operatingleaseliability": 30200000,
    "lesseeoperatingleaseoptiontoterminate": "option to terminate the lease at the end of the sixth year",
    "areaofspaceleased": 39000,
    "lesseeoperatingleaseleasenotyetcommenceddescription": "In March 2020, the Company entered into an agreement to lease approximately 39,000 square feet of office and laboratory space at 281 Albany Street in Cambridge, Massachusetts under an operating lease agreement (the “281 Albany Lease”).",
    "lesseeoperatingleaseleasenotyetcommencedtermofcontract1": "P10Y",
    "lesseeoperatingleaseleasenotyetcommencedoptiontoextend": "The Company has the option to extend the 281 Albany Lease for two successive five-year terms",
    "lesseeoperatingleasediscountrate": 0.0799,
    "prepaidlease": 500000,
    "operatingleasecost": 18031000,
    "variableleasecost": 4443000,
    "leasecost": 22474000,
    "operatingleasepayments": 14656000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 67053000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y10M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.072,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 25431000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 24930000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 25902000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 25078000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 17530000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 51557000,
    "lesseeoperatingleaseliabilitypaymentsdue": 170428000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 39725000,
    "allocatedsharebasedcompensationexpense": 56279000,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Stock options granted under the 2015 Plan generally vest 25% on the first anniversary of the original vesting date, with the balance vesting monthly over the remaining three years, unless they contain specific performance-based vesting provisions. The maximum term of stock options granted under the 2015 Plan is ten years.",
    "commonstockcapitalsharesreservedforfutureissuance": 3541302,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 70.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalueamount": 10400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1736844,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 147674,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.019,
    "numberoftranches": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.762,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y10M24D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 99300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 57.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 42800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 93100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1941379,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiod": 100817,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 70.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 70.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiodweightedaveragegrantdatefairvalue": 75.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0022,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0252,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.636,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.953,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5471675,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 391910,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 341437,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3216725,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 49.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 86.08,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 16.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 61.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 36.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y4M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y9M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 53736000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 40938000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1941000,
    "sharesissuedpricepershare": 57.43,
    "legalaccountingandotherfees": 200000,
    "numberofremainingshareseligibleforsaleunderagreementvalue": 205000000,
    "contrarevenue": 2000000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.5,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 2700000
  },
  {
    "date": "2021-12-30",
    "symbol": "NTLA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NTLA",
    "entityregistrantname": "INTELLIA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1652130,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-37766",
    "entitytaxidentificationnumber": "36-4785571",
    "entityaddressaddressline1": "40 Erie Street",
    "entityaddressaddressline2": "Suite 130",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "285-6200",
    "entityincorporationstatecountrycode": "DE",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 123406000,
    "marketablesecuritiescurrent": 625282000,
    "accountsreceivablenetcurrent": 2031000,
    "prepaidexpenseandotherassetscurrent": 18584000,
    "assetscurrent": 769303000,
    "marketablesecuritiesnoncurrent": 337361000,
    "propertyplantandequipmentnet": 20968000,
    "operatingleaserightofuseasset": 79143000,
    "equitymethodinvestments": 58131000,
    "investmentsandothernoncurrentassets": 29558000,
    "assets": 1294464000,
    "accountspayablecurrent": 9653000,
    "accruedliabilitiescurrent": 43309000,
    "operatingleaseliabilitycurrent": 9112000,
    "contractwithcustomerliabilitycurrent": 63759000,
    "liabilitiescurrent": 125833000,
    "contractwithcustomerliabilitynoncurrent": 63476000,
    "operatingleaseliabilitynoncurrent": 64911000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 1745870000,
    "accumulatedothercomprehensiveincomelossnetoftax": -2632000,
    "retainedearningsaccumulateddeficit": -703001000,
    "stockholdersequity": 1040244000,
    "liabilitiesandstockholdersequity": 1294464000,
    "accountsreceivablerelatedpartiescurrent": 100000,
    "investmentsandotherassetsfromrelatedpartiescurrent": 10000000,
    "contractwithcustomerliabilityrelatedpartycurrent": 41200000,
    "contractwithcustomerliabilityrelatedpartynoncurrent": 19900000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 74485883,
    "commonstocksharesoutstanding": 74485883,
    "revenuefromcontractwithcustomerexcludingassessedtax": 33053000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseAndServiceMember",
    "researchanddevelopmentexpense": 229807000,
    "generalandadministrativeexpense": 71096000,
    "costsandexpenses": 300903000,
    "operatingincomeloss": -267850000,
    "incomelossfromequitymethodinvestments": 1325000,
    "investmentincomeinterest": 1283000,
    "othernonoperatingincomeexpense": 42000,
    "netincomeloss": -267892000,
    "earningspersharebasicanddiluted": -3.78,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 70894,
    "marketablesecuritiesunrealizedgainloss": -2126000,
    "othercomprehensiveincomelossreclassificationadjustmentfromaociforinvestmenttransferredfromavailableforsaletoequitymethodtax": -507000,
    "comprehensiveincomenetoftax": -270525000,
    "revenuefromrelatedparties": 6072000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 284000,
    "stockissuedduringperiodvaluenewissues": 648315000,
    "stockissuedduringperiodsharesnewissues": 4758620,
    "stockissuedduringperiodvaluestockoptionsexercised": 41094000,
    "stockissuedduringperiodsharesstockoptionsexercised": 2700886,
    "numberofvestingrestrictedstockunits": 119715,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 2024000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 30897,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 47009000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -2126000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -507000,
    "profitloss": -267892000,
    "depreciationdepletionandamortization": 6891000,
    "sharebasedcompensation": 47009000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -7604000,
    "equitymethodinvestmentdeferredgainonsale": 2937000,
    "increasedecreaseinaccountsreceivable": -99000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 9798000,
    "increasedecreaseinoperatingrightofuseassets": -9349000,
    "increasedecreaseinotheroperatingassets": -117000,
    "increasedecreaseinaccountspayable": 529000,
    "increasedecreaseinaccruedliabilities": 17260000,
    "increasedecreaseincontractwithcustomerliability": -31355000,
    "increasedecreaseinoperatingleaseliabilities": -9105000,
    "netcashprovidedbyusedinoperatingactivities": -225030000,
    "paymentstoacquirepropertyplantandequipment": 12756000,
    "paymentstoacquiremarketablesecurities": 1020620000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 485598000,
    "paymentsforpurchaseofinvestments": 3000000,
    "netcashprovidedbyusedininvestingactivities": -550778000,
    "proceedsfromissuanceofcommonstock": 648315000,
    "proceedsfromstockoptionsexercised": 41094000,
    "proceedsfromstockplans": 2024000,
    "netcashprovidedbyusedinfinancingactivities": 736688000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -39120000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 125486000,
    "restrictedcashequivalents": 2080000,
    "capitalexpendituresincurredbutnotyetpaid": 667000,
    "rightofuseassetsacquiredunderoperatinglease": 49378000,
    "noncashcontributionofintellectualproperty": 62900000,
    "lesseeoperatingleaseleasenotyetcommencedtermofcontract1": "P10Y",
    "percentagelikelihoodofrealizationrequiredtorecordtaxbenefit": 0.5,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "5 years or term of respective lease, if shorter",
    "availableforsaledebtsecuritiesamortizedcostbasis": 301493000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1016000,
    "availableforsalesecuritiesdebtsecurities": 300477000,
    "availableforsalessecuritiesnoncurrentmaturityperiod": "P1Y",
    "cashandcashequivalentsfairvaluedisclosure": 124636000,
    "investmentsfairvaluedisclosure": 300477000,
    "assetsfairvaluedisclosure": 1087279000,
    "propertyplantandequipmentgross": 39840000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 26114000,
    "employeerelatedliabilitiescurrent": 20359000,
    "accruedresearchanddevelopmentexpensescurrent": 16979000,
    "accruedprofessionalfeescurrent": 3100000,
    "otheraccruedliabilitiescurrent": 2871000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.166,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.087,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.168,
    "effectiveincometaxratereconciliationonesixtytwom": 0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.629,
    "deferredtaxassetsinprocessresearchanddevelopment": 1010000,
    "deferredtaxassetsdeferredexpensecapitalizedstartup": 334000,
    "deferredtaxassetsoperatinglosscarryforwards": 216629000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 61698000,
    "deferredtaxassetsoperatingleaseliability": 20055000,
    "deferredtaxassetsdeferredincome": 13922000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7774000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 3718000,
    "prepaidrent": 1393000,
    "deferredtaxassetsequitymethodinvestments": 359000,
    "deferredtaxassetsgross": 326892000,
    "deferredtaxassetsvaluationallowance": 304781000,
    "deferredtaxassetsnet": 22111000,
    "deferredtaxliabilitiespropertyplantandequipment": 669000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": -21442000,
    "deferredincometaxliabilities": 22111000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 800500000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 37200000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetsoperatinglosscarryforwardsbeginstoexpireyear": 2034,
    "netoperatinglosscarryoverpercentageoftaxableincome": 1,
    "periodforwhichtaxableincomeavailablefromlosswasgenerated": "P20Y",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 763300000,
    "increaseindeferredtaxassetsvaluationallowance": 163900000,
    "deferredtaxassetstaxcreditcarryforwards": 37900000,
    "deferredtaxassetstaxcreditcarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetstaxcreditcarryforwardsbegintoexpireyear": 2034,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2029,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationdescription": "begin to expire in 2029",
    "contractwithcustomerliabilityadditions": 2900000,
    "increaseinaccountsreceivables": 7559000,
    "decreaseinaccountsreceivables": 7658000,
    "contractwithcustomerliability": 127235000,
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinmeasureofprogress": 84659000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": -31355000,
    "contractwithcustomerliabilityrevenuerecognized": 22544000,
    "collaborationpayment": 5000000,
    "saleofstocknumberofsharesissuedintransaction": 3739515,
    "saleofstockconsiderationreceivedontransaction": 3000000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "Through December 31, 2021",
    "paymentsduefromaffiliates": 5900000,
    "revenueremainingperformanceobligation": 51400000,
    "accountsreceivablerelatedparties": 2000000,
    "collaborationtransactionprice": 62900000,
    "equitymethodinvestmentownershippercentage": 0.3333,
    "strategiccollaborationagreementamendeddate": "2018-12",
    "onetimepaymenttonovartis": 10000000,
    "increasedecreaseinestimatedfuturedevelopmentcosts": 50000,
    "developmentcostsandpayroyalties": 0.5,
    "optinfee": 10000,
    "sharesofseriesa2preferredstock": 83316,
    "equityownership": 0.11,
    "investmentownedatfairvalue": 10000000,
    "saleofstockconsiderationreceivedpertransaction": 7000,
    "lesseeoperatingleasedescription": "In October 2014, the Company entered into an agreement to lease office and laboratory space at 130 Brookline Street (the “130 Brookline Lease”) in Cambridge, Massachusetts under an operating lease agreement with a term through January 2020, with an option to extend the term of the lease for an additional five-year period. In April 2019, the lease was amended to extend the term for the additional five-year period, through January 2025.",
    "lesseeoperatingleaseextendedexpirationdate": "2031-01-31",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "option to extend the term of the lease for an additional five-year period. In April 2019, the lease was amended to extend the term for the additional five-year period, through January 2025",
    "lesseeoperatingleaserenewalterm": "P6Y",
    "lesseeoperatingsubleaseoptiontoextend": "two options to extend the agreement by one year each, for a total option period of up to two years.",
    "operatingleaseliability": 74023000,
    "lesseeoperatingleaseoptiontoterminate": "option to terminate the lease at the end of the sixth year",
    "areaofspaceleased": 39000,
    "lesseeoperatingleaseleasenotyetcommenceddescription": "In March 2020, the Company entered into an agreement to lease approximately 39,000 square feet of office and laboratory space at 281 Albany Street in Cambridge, Massachusetts under an operating lease agreement (the “281 Albany Lease”).",
    "lesseeoperatingleaseleasenotyetcommencedannualbaserentpersquarefootforfirstyear": 74,
    "lesseeoperatingleaseleasenotyetcommencedbaserentpersquarefootforlastyear": 83.29,
    "lesseeoperatingleaseleasenotyetcommencedexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseleasenotyetcommencedoptiontoextend": "The Company has the option to extend the 281 Albany Lease for two successive five-year terms",
    "operatingleasecost": 12871000,
    "shorttermleasecost": 31000,
    "variableleasecost": 3339000,
    "leasecost": 16241000,
    "operatingleasepayments": 12641000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 49378000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.055,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 12929000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 13398000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 12320000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 12838000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 11544000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 28809000,
    "lesseeoperatingleaseliabilitypaymentsdue": 91838000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 17815000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Stock options granted under the 2015 Plan generally vest 25% on the first anniversary of the original vesting date, with the balance vesting monthly over the remaining three years, unless they contain specific performance-based vesting provisions. The maximum term of stock options granted under the 2015 Plan is ten years.",
    "commonstockcapitalsharesreservedforfutureissuance": 2241278,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 453026,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 73.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiod": 72467,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalueamount": 14100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 119715,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 27100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 451272,
    "allocatedsharebasedcompensationexpense": 26712000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 54.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 262000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 130300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6305156,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 453000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 700700,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 71.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 20.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiodweightedaveragegrantdatefairvalue": 45.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.729,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2729302,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2227760,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 43.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 84.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 15.22,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 30.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 16.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y4M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y5M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 492968000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 226941000,
    "sharesissuedpricepershare": 72.79,
    "percentageofgrossproceedsfromcommonstockassalesagentcashcommission": 0.03,
    "legalaccountingandotherfees": 100,
    "numberofremainingshareseligibleforsaleunderagreementvalue": 47400000,
    "revenuefromcontractwithcustomerincludingassessedtax": 5900,
    "definedcontributionplanemployermatchingcontributionpercent": 0.5,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1600000
  },
  {
    "date": "2020-12-30",
    "symbol": "NTLA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NTLA",
    "entityregistrantname": "INTELLIA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1652130,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large accelerated filer",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-37766",
    "entitytaxidentificationnumber": "36-4785571",
    "entityaddressaddressline1": "40 Erie Street",
    "entityaddressaddressline2": "Suite 130",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "285-6200",
    "entityincorporationstatecountrycode": "Delaware",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Global Market",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 160020000,
    "marketablesecuritiescurrent": 437351000,
    "accountsreceivablenetcurrent": 2130000,
    "prepaidexpenseandotherassetscurrent": 17016000,
    "assetscurrent": 616517000,
    "propertyplantandequipmentnet": 15943000,
    "operatingleaserightofuseasset": 39114000,
    "otherassetsnoncurrent": 4748000,
    "assets": 676322000,
    "accountspayablecurrent": 10460000,
    "accruedliabilitiescurrent": 25554000,
    "operatingleaseliabilitycurrent": 5696000,
    "contractwithcustomerliabilitycurrent": 22544000,
    "liabilitiescurrent": 64254000,
    "contractwithcustomerliabilitynoncurrent": 51387000,
    "operatingleaseliabilitynoncurrent": 33609000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 962173000,
    "accumulatedothercomprehensiveincomelossnetoftax": 1000,
    "retainedearningsaccumulateddeficit": -435109000,
    "stockholdersequity": -435109000,
    "liabilitiesandstockholdersequity": 676322000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 5000000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 150408000,
    "generalandadministrativeexpense": 44169000,
    "costsandexpenses": 194577000,
    "operatingincomeloss": -136583000,
    "investmentincomeinterest": 2352000,
    "netincomeloss": -134231000,
    "earningspersharebasicanddiluted": -2.4,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 55987000,
    "marketablesecuritiesunrealizedgainloss": -260000,
    "comprehensiveincomenetoftax": -134491000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 669000,
    "stockissuedduringperiodvaluenewissues": 49461000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 11574000,
    "stockissuedduringperiodsharesstockoptionsexercised": 840824,
    "numberofvestingrestrictedstockunits": 82829,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1557000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 101911,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 19903000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -260000,
    "profitloss": -134231000,
    "depreciationdepletionandamortization": 6311000,
    "gainlossonsaleofpropertyplantequipment": -35000,
    "sharebasedcompensation": 19903000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -538000,
    "increasedecreaseinaccountsreceivable": -2490000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 9206000,
    "increasedecreaseinoperatingrightofuseassets": -6457000,
    "increasedecreaseinotheroperatingassets": -83000,
    "increasedecreaseinaccountspayable": 5060000,
    "increasedecreaseinaccruedliabilities": 13031000,
    "increasedecreaseincontractwithcustomerliability": 45121000,
    "increasedecreaseinoperatingleaseliabilities": -5504000,
    "netcashprovidedbyusedinoperatingactivities": -49912000,
    "paymentstoacquirepropertyplantandequipment": 3585000,
    "paymentstoacquiremarketablesecurities": 473702000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 262800000,
    "netcashprovidedbyusedininvestingactivities": -214487000,
    "proceedsfromissuanceofcommonstock": 49500000,
    "proceedsfromstockoptionsexercised": 11574000,
    "proceedsfromstockplans": 1557000,
    "netcashprovidedbyusedinfinancingactivities": 371779000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 107380000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 164606000,
    "restrictedcashequivalents": 2700000,
    "capitalexpendituresincurredbutnotyetpaid": 1508000,
    "rightofuseassetsacquiredunderoperatinglease": 26432000,
    "proceedsfromdebtnetofissuancecosts": 200000,
    "lesseeoperatingleaseleasenotyetcommencedtermofcontract1": "ten years",
    "percentagelikelihoodofrealizationrequiredtorecordtaxbenefit": 0.5,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "5 years or term of respective lease, if shorter",
    "availableforsaledebtsecuritiesamortizedcostbasis": 437350000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 23000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 22000,
    "availableforsalesecuritiesdebtsecurities": 437351000,
    "availableforsalessecuritiesnoncurrentmaturityperiod": "five years",
    "cashandcashequivalentsfairvaluedisclosure": 163805000,
    "investmentsfairvaluedisclosure": 195687000,
    "assetsfairvaluedisclosure": 195687000,
    "propertyplantandequipmentgross": 35274000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 19331000,
    "employeerelatedliabilitiescurrent": 10920000,
    "accruedresearchanddevelopmentexpensescurrent": 11008000,
    "accruedprofessionalfeescurrent": 1876000,
    "otheraccruedliabilitiescurrent": 1750000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.07400000000000001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.018000000000000002,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.013000000000000001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.315,
    "deferredtaxassetsinprocessresearchanddevelopment": 981000,
    "deferredtaxassetsdeferredexpensecapitalizedstartup": 378000,
    "deferredtaxassetsoperatinglosscarryforwards": 101807000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10300000,
    "deferredtaxassetsoperatingleaseliability": 10713000,
    "deferredtaxassetsdeferredincome": 4680000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8574000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 2200000,
    "deferredtaxassetsgross": 152499000,
    "deferredtaxassetsvaluationallowance": 140868000,
    "deferredtaxassetsnet": 11631000,
    "deferredtaxliabilitiespropertyplantandequipment": 970000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 10661000,
    "deferredincometaxliabilities": 11631000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 372500000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 373100000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetsoperatinglosscarryforwardsbeginstoexpireyear": 2034,
    "netoperatinglosscarryoverpercentageoftaxableincome": 0.8,
    "periodforwhichtaxableincomeavailablefromlosswasgenerated": "twenty years",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 335300000,
    "increaseindeferredtaxassetsvaluationallowance": 42400000,
    "deferredtaxassetstaxcreditcarryforwards": 15000000,
    "deferredtaxassetstaxcreditcarryforwardsexpirationdescription": "begin to expire in 2034",
    "deferredtaxassetstaxcreditcarryforwardsbegintoexpireyear": 2034,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2029,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationdescription": "begin to expire in 2029",
    "increaseinaccountsreceivables": 103116000,
    "decreaseinaccountsreceivables": 105606000,
    "contractwithcustomerliability": 73900000,
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinmeasureofprogress": 87477000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": -42356000,
    "contractwithcustomerliabilityrevenuerecognized": 11571000,
    "contractwithcustomerliabilityadditions": 62400000,
    "proceedsfromissuanceofprivateplacement": 50000000,
    "collaborationagreementfurtheroptionextensionperiod": "two",
    "numberofperformanceobligations": 3,
    "transactionprice": 110900000,
    "transactionpriceallocatedtocommonstock": 50000000,
    "remainingtransactionpriceallocatedtocombinedperformanceobligation": 75000000,
    "amountallocatedtolicensestotargetsandassociatedresearchactivitiesandevaluationplans": 91900000,
    "amountallocatedtotechnologycollaborationandresearchactivities": 3700000,
    "licensestotargetsandassociatedresearchactivitiesandevaluationplansperformanceperiod": "six years",
    "cumulativecatchupadjustment": 8400000,
    "remainingtransactionpricetransferredatinceptionofarrangement": 23500000,
    "premiumonsaleofshares": 17400000,
    "proceedsfromissuanceorsaleofequity": 12600000,
    "transactionpriceallocatedtocombinedperformanceobligation": 110900000,
    "amountallocatedtotransferlicensetodevelopfactorviiitargetforhemophiliaa": 15300000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "Through December 31, 2020",
    "paymentsduefromaffiliates": 10700000,
    "revenueremainingperformanceobligation": 73900000,
    "accountsreceivablerelatedparties": 2100000,
    "strategiccollaborationagreementamendeddate": "December 2018",
    "lesseeoperatingleasedescription": "In January 2016, the Company entered into a ten-year agreement to lease office and laboratory space at 40 Erie Street (the “40 Erie Lease”) in Cambridge, Massachusetts under an operating lease agreement, with an option to terminate the lease at the end of the sixth year and an option to extend the term of the lease for an additional three years.",
    "lesseeoperatingleaseextendedexpirationdate": "January 31, 2031",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "option to extend the term of the lease for an additional three years.",
    "lesseeoperatingleaserenewalterm": "six years",
    "lesseeoperatingsubleaseoptiontoextend": "two options to extend the agreement by one year each, for a total option period of up to two years.",
    "operatingleaseliability": 39305000,
    "lesseeoperatingleaseoptiontoterminate": "option to terminate the lease at the end of the sixth year",
    "areaofspaceleased": 39000,
    "lesseeoperatingleaseleasenotyetcommenceddescription": "In March 2020, the Company entered into an agreement to lease approximately 39,000 square feet of office and laboratory space at 281 Albany Street in Cambridge, Massachusetts under an operating lease agreement (the “281 Albany Lease”). The Company’s obligation to pay rent will start on the date that is six months after the commencement date or the date on which the Company occupies the premises, whichever occurs earlier (the “Rent Commencement Date”).",
    "lesseeoperatingleaseleasenotyetcommencedannualbaserentpersquarefootforfirstyear": 99,
    "lesseeoperatingleaseleasenotyetcommencedbaserentpersquarefootforlastyear": 128.87,
    "accountsreceivablebilledforlongtermcontractsorprogramsadditions": 4400000,
    "lineofcredit": 1900000,
    "lesseeoperatingleaseleasenotyetcommencedexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseleasenotyetcommencedoptiontoextend": "The Company has the option to extend the 281 Albany Lease for two successive five-year terms.",
    "operatingleasecost": 8447000,
    "shorttermleasecost": 56000,
    "variableleasecost": 2918000,
    "leasecost": 11421000,
    "operatingleasepayments": 7495000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 26432000,
    "operatingleaseweightedaverageremainingleaseterm1": 6.7,
    "operatingleaseweightedaveragediscountratepercent": 0.057999999999999996,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 7803000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 6604000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6744000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 6934000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 7322000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 13631000,
    "lesseeoperatingleaseliabilitypaymentsdue": 49038000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 9733000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "three years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Stock options granted under the 2015 Plan generally vest 25% on the first anniversary of the original vesting date, with the balance vesting monthly over the remaining three years, unless they contain specific performance-based vesting provisions. The maximum term of stock options granted under the 2015 Plan is ten years.",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 193936,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 21.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiod": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 2,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 3800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 260336,
    "sharebasedcompensationarrangementbysharebasedpaymentawardacceleratedvestingnumber": 58870,
    "allocatedsharebasedcompensationexpense": 300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 20300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 33700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 77916,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "performance-based stock options that vest upon obtaining certain scientific, financial and regulatory milestones through 2020.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 47916,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7171000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 125834,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 23.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 17.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiodweightedaveragegrantdatefairvalue": 21.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6779999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 15.43,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 15.04,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 13.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 18.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 15.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 271940000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 115608000,
    "sharesissuedpricepershare": 22.53,
    "percentageofgrossproceedsfromcommonstockassalesagentcashcommission": 0.03,
    "legalaccountingandotherfees": 200000,
    "numberofremainingshareseligibleforsaleunderagreementvalue": 94100000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.5,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1100000
  },
  {
    "date": "2019-12-30",
    "symbol": "NTLA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2019",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NTLA",
    "entityregistrantname": "INTELLIA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1652130,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-37766",
    "entitytaxidentificationnumber": "36-4785571",
    "entityaddressaddressline1": "40 Erie Street",
    "entityaddressaddressline2": "Suite 130",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "285-6200",
    "entityincorporationstatecountrycode": "Delaware",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Global Market",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 57226000,
    "marketablesecuritiescurrent": 222500000,
    "accountsreceivablenetcurrent": 4620000,
    "prepaidexpenseandotherassetscurrent": 5135000,
    "assetscurrent": 289481000,
    "marketablesecuritiesnoncurrent": 4746000,
    "propertyplantandequipmentnet": 17996000,
    "operatingleaserightofuseasset": 19137000,
    "otherassetsnoncurrent": 2920000,
    "assets": 334280000,
    "accountspayablecurrent": 3941000,
    "accruedliabilitiescurrent": 13273000,
    "operatingleaseliabilitycurrent": 5745000,
    "contractwithcustomerliabilitycurrent": 12674000,
    "liabilitiescurrent": 35633000,
    "contractwithcustomerliabilitynoncurrent": 16136000,
    "operatingleaseliabilitynoncurrent": 12630000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 570493000,
    "accumulatedothercomprehensiveincomelossnetoftax": 261000,
    "retainedearningsaccumulateddeficit": -300878000,
    "stockholdersequity": -300878000,
    "liabilitiesandstockholdersequity": 334280000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 18500000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 108413000,
    "generalandadministrativeexpense": 41058000,
    "costsandexpenses": 149471000,
    "operatingincomeloss": -106368000,
    "investmentincomeinterest": 6835000,
    "netincomeloss": -99533000,
    "earningspersharebasicanddiluted": -2.11,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 47247000,
    "marketablesecuritiesunrealizedgainloss": 289000,
    "comprehensiveincomenetoftax": -99244000,
    "cumulativeeffectofnewaccountingprincipleinperiodofadoption": -320000,
    "stockissuedduringperiodvaluenewissues": 72256000,
    "stockissuedduringperiodsharesnewissues": 287231,
    "stockissuedduringperiodvaluestockoptionsexercised": 3086000,
    "stockissuedduringperiodsharesstockoptionsexercised": 364404,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1092000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 90581,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 15091000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 289000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 363000,
    "profitloss": -99533000,
    "depreciationdepletionandamortization": 5587000,
    "gainlossonsaleofpropertyplantequipment": -1000,
    "sharebasedcompensation": 15091000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 3725000,
    "increasedecreaseinaccountsreceivable": -2927000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1763000,
    "increasedecreaseinoperatingrightofuseassets": -5728000,
    "increasedecreaseinotheroperatingassets": -153000,
    "increasedecreaseinaccountspayable": 1880000,
    "increasedecreaseinaccruedliabilities": 2310000,
    "increasedecreaseincontractwithcustomerliability": -27122000,
    "increasedecreaseinoperatingleaseliabilities": -4774000,
    "netcashprovidedbyusedinoperatingactivities": -103240000,
    "paymentstoacquirepropertyplantandequipment": 6794000,
    "paymentstoacquiremarketablesecurities": 297030000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 329000000,
    "netcashprovidedbyusedininvestingactivities": 25176000,
    "proceedsfromissuanceofcommonstock": 4400000,
    "proceedsfromstockoptionsexercised": 3086000,
    "proceedsfromstockplans": 1092000,
    "netcashprovidedbyusedinfinancingactivities": 76434000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1630000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 57226000,
    "capitalexpendituresincurredbutnotyetpaid": 800000,
    "rightofuseassetsacquiredunderoperatinglease": 2554000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "5 years or term of respective lease, if shorter",
    "percentagelikelihoodofrealizationrequiredtorecordtaxbenefit": 0.5,
    "numberofreportablesegments": 1,
    "lesseeoperatingleasetermofcontract": 12,
    "operatingleaseliability": 18375000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 226985000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 262000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "availableforsalesecuritiesdebtsecurities": 227246000,
    "availableforsalessecuritiesnoncurrentmaturityperiod": "five years",
    "cashandcashequivalentsfairvaluedisclosure": 46917000,
    "investmentsfairvaluedisclosure": 67744000,
    "assetsfairvaluedisclosure": 67744000,
    "propertyplantandequipmentgross": 31864000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 13868000,
    "employeerelatedliabilitiescurrent": 6311000,
    "accruedresearchanddevelopmentexpensescurrent": 4208000,
    "accruedprofessionalfeescurrent": 1563000,
    "otheraccruedliabilitiescurrent": 1191000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.08900000000000001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.051,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.012,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.33799999999999997,
    "deferredtaxassetsinprocessresearchanddevelopment": 1091000,
    "deferredtaxassetsdeferredexpensecapitalizedstartup": 421000,
    "deferredtaxassetsoperatinglosscarryforwards": 63245000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 8700000,
    "deferredtaxassetsoperatingleaseliability": 5008000,
    "deferredtaxassetsdeferredincome": 7843000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7092000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 1245000,
    "deferredtaxassetsgross": 105362000,
    "deferredtaxassetsvaluationallowance": 98513000,
    "deferredtaxassetsnet": 6849000,
    "deferredtaxliabilitiespropertyplantandequipment": 1633000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 5216000,
    "deferredincometaxliabilities": 6849000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 36900000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 236800000,
    "deferredtaxassetsoperatinglosscarryforwardsbeginstoexpireyear": 2034,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationdescription": "begins to expire in 2034",
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2031,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationdescription": "begin to expire in 2035 and 2031",
    "increaseindeferredtaxassetsvaluationallowance": 34500000,
    "increaseinaccountsreceivable": 15999000,
    "decreaseinaccountsreceivable": 18926000,
    "contractwithcustomerliability": 28800000,
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinmeasureofprogress": 4000000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": -31122000,
    "contractwithcustomerliabilityrevenuerecognized": 27122000,
    "strategiccollaborationagreementamendeddate": "December 2018",
    "regulatorybasedmilestonepaymentsunderagreement": 5000000,
    "contractwithcustomerliabilityadditions": 75000000,
    "technologyaccessfees": 20000000,
    "quarterlyresearchpayments": 20000000,
    "researchpayments": 19000000,
    "proceedsfromissuanceofpreferredstockandpreferencestock": 9000000,
    "terminationofagreementnoticeperiod": 90,
    "numberofperformanceobligations": 3,
    "transactionprice": 125000000,
    "transactionpriceallocatedtoequity": 11600000,
    "remainingtransactionpriceallocatedtocombinedperformanceobligationoflicensesandassociatedresearchactivities": 47400000,
    "combinedperformanceobligationoflicensesandassociatedresearchactivitiesrevenuerecognitionperiod": "one year",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "through April 2022",
    "accountsreceivablerelatedparties": 1000000,
    "proceedsfromissuanceofprivateplacement": 50000000,
    "transactionpriceallocatedtocommonstock": 50000000,
    "remainingtransactionpriceallocatedtocombinedperformanceobligation": 75000000,
    "amountallocatedtolicensestotargetsandassociatedresearchactivitiesandevaluationplans": 63800000,
    "amountallocatedtotechnologycollaborationandresearchactivities": 11200000,
    "licensestotargetsandassociatedresearchactivitiesandevaluationplansperformanceperiod": "six years",
    "paymentsduefromaffiliates": 12000000,
    "revenueremainingperformanceobligation": 28800000,
    "accountsreceivablenet": 3600000,
    "lesseeoperatingleasedescription": "In January 2016, the Company entered into a ten-year agreement to lease office and laboratory space at 40 Erie Street in Cambridge, Massachusetts under an operating lease agreement, with an option to terminate the lease at the end of the sixth year and an option to extend the term of the lease for an additional three years.",
    "lesseeoperatingleaseoptiontoextend": "option to extend the term of the lease for an additional three years.",
    "lesseeoperatingsubleaseoptiontoextend": "two options to extend the agreement by one year each, for a total option period of up to two years.",
    "lesseeoperatingleaseoptiontoterminate": "option to terminate the lease at the end of the sixth year",
    "operatingleasecost": 7431000,
    "shorttermleasecost": 53000,
    "variableleasecost": 2218000,
    "leasecost": 9702000,
    "operatingleasepayments": 6476000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2554000,
    "operatingleaseweightedaverageremainingleaseterm1": 3,
    "operatingleaseweightedaveragediscountratepercent": 0.09,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 7113000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 7350000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4733000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 871000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 871000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 73000,
    "lesseeoperatingleaseliabilitypaymentsdue": 21011000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2636000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "three years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Stock options granted under the 2015 Plan generally vest 25% on the first anniversary of the original vesting date, with the balance vesting monthly over the remaining three years, unless they contain specific performance-based vesting provisions. The maximum term of stock options granted under the 2015 Plan is ten years. ",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.5,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5438000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 28200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 213750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "performance-based stock options that vest upon obtaining certain scientific, financial and regulatory milestones through 2020.",
    "allocatedsharebasedcompensationexpense": 15091000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 71875,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 37198,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 22.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.021,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6809999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 527901,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 15.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 18.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 9082000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 8017000,
    "sharesissuedpricepershare": 16.48,
    "convertiblepreferredstocktermsofconversion": "one-for-0.6465903",
    "percentageofgrossproceedsfromcommonstockassalesagentcashcommission": 0.03,
    "legalaccountingandotherfees": 200000,
    "numberofremainingshareseligibleforsaleunderagreementvalue": 145300000,
    "relatedpartyownershippercentage": 0.1,
    "definedcontributionplanemployermatchingcontributionpercent": 0.5,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 800000
  }
]